Current challenges facing the clinical treatment for HTLV-1 ocular manifestations

References

• Temin HM, Baltimore D. RNA-directed DNA synthesis and RNA tumor viruses. Adv Virus Res. 1972;17:129–186.
   PubMedGoogle Scholar
• Poiesz BJ, Ruscetti FW, Gazdar AF, et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980;77(12):7415–7419. doi: 10.1073/pnas.77.12.7415
   PubMed Web of Science ®Google Scholar
• Hinuma Y, Nagata K, Hanaoka M, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A. 1981;78(10):6476–6480. doi: 10.1073/pnas.78.10.6476
   PubMed Web of Science ®Google Scholar
• Yoshida M, Seiki M, Yamaguchi K, et al. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc Natl Acad Sci U S A. 1984;81(8):2534–2537. doi: 10.1073/pnas.81.8.2534
   PubMed Web of Science ®Google Scholar
• Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388. doi: 10.3389/fmicb.2012.00388
   PubMed Web of Science ®Google Scholar
• Gruber K. Australia tackles HTLV-1. Lancet Infect Dis. 2018;18(10):1073–1074. doi: 10.1016/S1473-3099(18)30561-9
   PubMed Web of Science ®Google Scholar
• Nishijima T, Shimada S, Noda H, et al. Towards the elimination of HTLV-1 infection in Japan. Lancet Infect Dis. 2019;19(1):15–16. doi: 10.1016/S1473-3099(18)30735-7
   PubMed Web of Science ®Google Scholar
• Satake M, Yamaguchi K, Tadokoro K. Current prevalence of HTLV-1 in Japan as determined by screening of blood donors. J Med Virol. 2012;84(2):327–335. doi: 10.1002/jmv.23181
   PubMed Web of Science ®Google Scholar
• Einsiedel L, Woodman RJ, Flynn M, et al. Human T-Lymphotropic virus type 1 infection in an Indigenous Australian population: epidemiological insights from a hospital-based cohort study. BMC Public Health. 2016;16(1):787. doi: 10.1186/s12889-016-3366-5
   PubMedGoogle Scholar
• WHO. Human T-lymphotropic virus type 1: technical report. (2021).
   Google Scholar
• Afonso PV, Cassar O, Gessain A. Molecular epidemiology, genetic variability and evolution of HTLV-1 with special emphasis on African genotypes. Retrovirology. 2019;16(1):39. doi: 10.1186/s12977-019-0504-z
   PubMed Web of Science ®Google Scholar
• Watanabe T. HTLV-1-associated diseases. Int J Hematol. 1997;66(3):257–278. doi: 10.1016/S0925-5710(97)00077-7
   PubMed Web of Science ®Google Scholar
• Kamoi K. HTLV-1 in ophthalmology. Front Microbiol. 2020;11:388.
   PubMed Web of Science ®Google Scholar
• Ohba N, Matsumoto M, Sameshima M, et al. Ocular manifestations in patients infected with human T-lymphotropic virus type I. Jpn J Ophthalmol. 1989;33(1):1–12.
   PubMed Web of Science ®Google Scholar
• Mochizuki M, Watanabe T, Yamaguchi K, et al. HTLV-I uveitis: a distinct clinical entity caused by HTLV-I. Jpn J Cancer Res. 1992;83(3):236–239. doi: 10.1111/j.1349-7006.1992.tb00092.x
   PubMedGoogle Scholar
• Mochizuki M, Yamaguchi K, Takatsuki K, et al. HTLV-I and uveitis. Lancet. 1992;339(8801):1110. doi: 10.1016/0140-6736(92)90699-4
   PubMed Web of Science ®Google Scholar
• Kamoi K, Mochizuki M. HTLV-1 uveitis. Front Microbiol. 2012;3:270. doi: 10.3389/fmicb.2012.00270
   PubMed Web of Science ®Google Scholar
• Kamoi K, Watanabe T, Uchimaru K, et al. Updates on HTLV-1 uveitis. Viruses. 2022;14(4). doi: 10.3390/v14040794
   PubMed Web of Science ®Google Scholar
• Ikeda EOAHNA K, Mochizuki M, Yamaguchi K, et al. Estimated Prevalence Rate of HTLV-I Uveitis in Chikugo. J Japanese Ophthalmological Soc. 1998;102(5):327–332.
   Google Scholar
• Ijichi S, Osame M. Human T lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP): recent perspectives. Intern Med. 1995;34(8):713–721. doi: 10.2169/internalmedicine.34.713
   PubMed Web of Science ®Google Scholar
• Kamoi K, Mochizuki M. HTLV infection and the eye. Curr Opin Ophthalmol. 2012;23(6):557–561. doi: 10.1097/ICU.0b013e328358b9ec
   PubMed Web of Science ®Google Scholar
• Terada Y, Kamoi K, Komizo T, et al. Human T cell leukemia virus type 1 and eye diseases. J Ocul Pharmacol Ther. 2017;33(4):216–223. doi: 10.1089/jop.2016.0124
   PubMed Web of Science ®Google Scholar
• Nakao K, Abematsu N, Sakamoto T. Systemic diseases in patients with HTLV-1-associated uveitis. Br J Ophthalmol. 2018;102(3):373–376. doi: 10.1136/bjophthalmol-2017-310658
   PubMed Web of Science ®Google Scholar
• Nakao K, Ohba N, Otsuka S, et al. HTLV-I associated uveitis and hyperthyroidism. Jpn J Ophthalmol. 1994;38(1):56–61.
   PubMed Web of Science ®Google Scholar
• Yamaguchi K, Mochizuki M, Watanabe T, et al. Human T lymphotropic virus type 1 uveitis after graves’ disease. Br J Ophthalmol. 1994;78(3):163–166. doi: 10.1136/bjo.78.3.163
   PubMed Web of Science ®Google Scholar
• Kamoi K, Uchimaru K, Tojo A, et al. HTLV-1 uveitis and Graves’ disease presenting with sudden onset of blurred vision. Lancet. 2022;399(10319):60. doi: 10.1016/S0140-6736(21)02442-9
   PubMed Web of Science ®Google Scholar
• Mohanty S, Harhaj EW. Mechanisms of oncogenesis by HTLV-1 Tax. Pathogens. 2020;9(7):543. doi: 10.3390/pathogens9070543
   PubMed Web of Science ®Google Scholar
• Nakano K, Watanabe T. Tuning rex rules HTLV-1 pathogenesis. Front Immunol. 2022;13:959962. doi: 10.3389/fimmu.2022.959962
   PubMed Web of Science ®Google Scholar
• Matsuoka M, Mesnard JM. HTLV-1 bZIP factor: the key viral gene for pathogenesis. Retrovirology. 2020;17(1). doi: 10.1186/s12977-020-0511-0
   Web of Science ®Google Scholar
• Kamoi K, Yamamoto K, Misawa A, et al. SUV39H1 interacts with HTLV-1 Tax and abrogates Tax transactivation of HTLV-1 LTR. Retrovirology. 2006;3(5). doi: 10.1186/1742-4690-3-5
   PubMedGoogle Scholar
• Yamagishi M, Suzuki Y, Watanabe T, et al. Clonal selection and evolution of HTLV-1-Infected cells driven by genetic and epigenetic alteration. Viruses. 2022;14(3):587. doi: 10.3390/v14030587
   PubMed Web of Science ®Google Scholar
• Yamagishi M, Fujikawa D, Watanabe T, et al. HTLV-1-Mediated epigenetic pathway to adult T-Cell Leukemia-Lymphoma. Front Microbiol. 2018;9:1686. doi: 10.3389/fmicb.2018.01686
   PubMed Web of Science ®Google Scholar
• Yamamoto-Taguchi N, Satou Y, Miyazato P, et al. HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression. PLOS Pathog. 2013;9(9):e1003630. doi: 10.1371/journal.ppat.1003630
   PubMed Web of Science ®Google Scholar
• Kannagi M. Immunologic control of human T-cell leukemia virus type I and adult T-cell leukemia. Int J Hematol. 2007;86(2):113–117. doi: 10.1532/IJH97.07092
   PubMed Web of Science ®Google Scholar
• Sagawa K, Mochizuki M, Masuoka K, et al. Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis. Detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production. J Clin Invest. 1995;95(2):852–858. doi: 10.1172/JCI117735
   PubMed Web of Science ®Google Scholar
• Masuoka K, Sagawa K, Mochizuki M, et al. Polyclonal use of T-cell receptor alpha for human T-cell lymphotropic virus type 1-infected T cells. Invest Ophthalmol Vis Sci. 1995;36(1):254–258.
   PubMed Web of Science ®Google Scholar
• Ono A, Mochizuki M, Yamaguchi K, et al. Increased number of circulating HTLV-1 infected cells in peripheral blood mononuclear cells of HTLV-1 uveitis patients: a quantitative polymerase chain reaction study. Br J Ophthalmol. 1995;79(3):270–276. doi: 10.1136/bjo.79.3.270
   PubMed Web of Science ®Google Scholar
• Ono A, Mochizuki M, Yamaguchi K, et al. Immunologic and virologic characterization of the primary infiltrating cells in the aqueous humor of human T-cell leukemia virus type-1 uveitis. Accumulation of the human T-cell leukemia virus type-1-infected cells and constitutive expression of viral and interleukin-6 messenger ribonucleic acids. Invest Ophthalmol Vis Sci. 1997;38(3):676–689.
   PubMed Web of Science ®Google Scholar
• Sagawa K, Mochizuki M, Katagirl K, et al. In vitro effects of immunosuppressive agents on cytokine production by HTLV-I-infected T cell clones derived from the ocular fluid of patients with HTLV-I uveitis. Microbiol Immunol. 1996;40(5):373–379. doi: 10.1111/j.1348-0421.1996.tb01082.x
   PubMed Web of Science ®Google Scholar
• Liu B, Li Z, Mahesh SP, et al. HTLV-1 infection of human retinal pigment epithelial cells and inhibition of viral infection by an antibody to ICAM-1. Invest Ophthalmol Vis Sci. 2006;47(4):1510–1515. doi: 10.1167/iovs.05-1277
   PubMed Web of Science ®Google Scholar
• Uchida M, Kamoi K, Ando N, et al. Safety of infliximab for the eye under human T-Cell leukemia virus type 1 infectious conditions in vitro. Front Microbiol. 2019;10:2148. doi: 10.3389/fmicb.2019.02148
   PubMed Web of Science ®Google Scholar
• Kurozumi-Karube H, Kamoi K, Ando N, et al. In vitro evaluation of the safety of adalimumab for the eye under HTLV-1 infection status: a preliminary study. Front Microbiol. 2020;11:522579. doi: 10.3389/fmicb.2020.522579
   PubMed Web of Science ®Google Scholar
• Zong Y, Kamoi K, Kurozumi-Karube H, et al. Safety of intraocular anti-VEGF antibody treatment under in vitro HTLV-1 infection. Front Immunol. 2022;13:1089286. doi: 10.3389/fimmu.2022.1089286
   PubMedGoogle Scholar
• Zong Y, Kamoi K, Ando N, et al. Mechanism of secondary glaucoma development in HTLV-1 uveitis. Front Microbiol. 2022;13:738742. doi: 10.3389/fmicb.2022.738742
   PubMed Web of Science ®Google Scholar
• Iwanaga M, Chiyoda S, Kusaba E, et al. Trends in the seroprevalence of HTLV-1 in Japanese blood donors in Nagasaki Prefecture, 2000-2006. Int J Hematol. 2009;90(2):186–190. doi: 10.1007/s12185-009-0366-6
   PubMed Web of Science ®Google Scholar
• Satake M, Iwanaga M, Sagara Y, et al. Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis. Lancet Infect Dis. 2016;16(11):1246–1254. doi: 10.1016/S1473-3099(16)30252-3
   PubMed Web of Science ®Google Scholar
• Kamoi K, Okayama A, Izumo S, et al. Tackling HTLV-1 infection in ophthalmology: a nationwide survey of ophthalmic care in an endemic country, Japan. Br J Ophthalmol. 2020;104(12):1647–1651. doi: 10.1136/bjophthalmol-2019-315675
   PubMed Web of Science ®Google Scholar
• Goncalves DU, Proietti FA, Ribas JG, et al. Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases. Clin Microbiol Rev. 2010;23(3):577–589. doi: 10.1128/CMR.00063-09
   PubMed Web of Science ®Google Scholar
• Rosadas C, Taylor GP. Mother-to-child HTLV-1 transmission: unmet research needs. Front Microbiol. 2019;10:999. doi: 10.3389/fmicb.2019.00999
   PubMed Web of Science ®Google Scholar
• Kamoi K, Horiguchi N, Kurozumi-Karube H, et al. Horizontal transmission of HTLV-1 causing uveitis. Lancet Infect Dis. 2021;21(4):578. doi: 10.1016/S1473-3099(21)00063-3
   PubMed Web of Science ®Google Scholar
• Bangham CR, Cook LB, Melamed A. HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection. Semin Cancer Biol. 2014;26:89–98. doi: 10.1016/j.semcancer.2013.11.003
   PubMed Web of Science ®Google Scholar
• Kamoi K, Mochizuki M. HTLV-1 Uveitis. In: Zierhut M, Pavesio C, Ohno S, Orefice F Rao N, editors Intraocular inflammation. Berlin Heidelberg: Springer Berlin Heidelberg; 2016. p. 1197–1201.
   Google Scholar
• Kamoi K, Mochizuki M. Human T-Cell Leukemia Virus Type 1. In: Chee S-P Khairallah M, editors Emerging infectious uveitis. Cham: Springer International Publishing; 2017. p. 143–148.
   Google Scholar
• Okuma K, Kuramitsu M, Niwa T, et al. Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan. Retrovirology. 2020;17(1):26. doi: 10.1186/s12977-020-00534-0
   PubMed Web of Science ®Google Scholar
• Kamoi K, Mochizuki M. Phaco dislocation technique in young patients with uveitis. J Cataract Refract Surg. 2008;34(8):1239–1241. doi: 10.1016/j.jcrs.2008.03.047
   PubMed Web of Science ®Google Scholar
• Kamoi K, Mochizuki M. Phaco forward-chop technique for managing posterior nuclear plate of hard cataract. J Cataract Refract Surg. 2010;36(1):9–12. doi: 10.1016/j.jcrs.2009.07.047
   PubMed Web of Science ®Google Scholar
• Nakamura H, Tsukamoto M, Nagasawa Y, et al. Does HTLV-1 infection show phenotypes found in Sjögren’s syndrome? Viruses. 2022;14(1):100. doi: 10.3390/v14010100
   PubMed Web of Science ®Google Scholar
• Green JE, Hinrichs SH, Vogel J, et al. Exocrinopathy resembling Sjogren’s syndrome in HTLV-1 tax transgenic mice. Nature. 1989;341(6237):72–74. doi: 10.1038/341072a0
   PubMed Web of Science ®Google Scholar
• Eguchi K, Matsuoka N, Ida H, et al. Primary Sjogren’s syndrome with antibodies to HTLV-I: clinical and laboratory features. Ann Rheum Dis. 1992;51(6):769–776. doi: 10.1136/ard.51.6.769
   PubMed Web of Science ®Google Scholar
• Terada K, Katamine S, Eguchi K, et al. Prevalence of serum and salivary antibodies to HTLV-1 in Sjogren’s syndrome. Lancet. 1994;344(8930):1116–1119. doi: 10.1016/S0140-6736(94)90630-0
   PubMed Web of Science ®Google Scholar
• Quaresma JA, Yoshikawa GT, Koyama RV, et al. HTLV-1, Immune Response and Autoimmunity. Viruses. 2015;8(1):5. doi: 10.3390/v8010005
   PubMed Web of Science ®Google Scholar
• Pinheiro SR, Martins-Filho OA, Ribas JG, et al. Immunologic markers, uveitis, and keratoconjunctivitis sicca associated with human T-cell lymphotropic virus type 1. Am J Ophthalmol. 2006;142(5):811–815. doi: 10.1016/j.ajo.2006.06.013
   PubMed Web of Science ®Google Scholar
• Rathsam-Pinheiro RH, Boa-Sorte N, Castro-Lima-Vargens C, et al. Ocular lesions in HTLV-1 infected patients from Salvador, state of Bahia: the city with the highest prevalence of this infection in Brazil. Rev Soc Bras Med Trop. 2009;42(6):633–637. doi: 10.1590/S0037-86822009000600004
   PubMed Web of Science ®Google Scholar
• Rathsam-Pinheiro RH, Boa-Sorte N, Grassi MFR, et al. Revisiting Keratoconjunctivitis sicca associated with human T-Cell lymphotropic virus type 1: prevalence, clinical aspects and proviral load. Braz J Infect Dis. 2019;23(2):95–101. doi: 10.1016/j.bjid.2019.04.002
   PubMed Web of Science ®Google Scholar
• Castro-Lima Vargens C, Grassi MF, Boa-Sorte N, et al. Keratoconjunctivitis sicca of human T cell lymphotropic virus type 1 (HTLV-1) infected individuals is associated with high levels of HTLV-1 proviral load. J Clin Virol. 2011;52(3):177–180. doi: 10.1016/j.jcv.2011.07.016
   PubMed Web of Science ®Google Scholar
• Buggage RR, Levy-Clarke GA, Smith JA. New corneal findings in human T-cell lymphotrophic virus type 1 infection. Am J Ophthalmol. 2001;131(3):309–313. doi: 10.1016/S0002-9394(00)00881-3
   PubMed Web of Science ®Google Scholar
• Merle H, Cabre P, Merle S, et al. A description of human T-lymphotropic virus type I-related chronic interstitial keratitis in 20 patients. Am J Ophthalmol. 2001;131(3):305–308. doi: 10.1016/S0002-9394(00)00645-0
   PubMed Web of Science ®Google Scholar
• Patronas M, Smith JA, Levy-Clarke GA, et al. Hypergammaglobulinemia and corneal opacities in patients with human T-cell lymphotrophic virus type-1. Am J Ophthalmol. 2006;142(6):1088–1089. doi: 10.1016/j.ajo.2006.07.028
   PubMed Web of Science ®Google Scholar
• Yoshida Y, Saiga T, Takahashi H, et al. Optic neuritis and human T-lymphotropic virus type 1-associated myelopathy: a case report. Ophthalmologica. 1998;212(1):73–76. doi: 10.1159/000027246
   PubMed Web of Science ®Google Scholar
• Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6(9):805–815. doi: 10.1016/S1474-4422(07)70216-8
   PubMed Web of Science ®Google Scholar
• Araujo AQ, Silva MT. The HTLV-1 neurological complex. Lancet Neurol. 2006;5(12):1068–1076. doi: 10.1016/S1474-4422(06)70628-7
   PubMed Web of Science ®Google Scholar
• Koga M, Takahashi T, Kawai M, et al. Neuromyelitis optica with HTLV-1 infection: different from acute progressive HAM? Intern Med. 2009;48(13):1157–1159. doi: 10.2169/internalmedicine.48.1989
   PubMed Web of Science ®Google Scholar
• Olindo S, Bonnan M, Merle H, et al. Neuromyelitis optica associated with subacute human T-lymphotropic virus type 1 infection. J Clin Neurosci. 2010;17(11):1449–1451. doi: 10.1016/j.jocn.2009.12.024
   PubMed Web of Science ®Google Scholar
• Kampylafka EI, Alexopoulos H, El Hamidieh A, et al. Immunization of mice with a peptide derived from the HTLV-1 TAX1BP1 protein induces cross-reactive antibodies against aquaporin 4. Autoimmunity. 2015;48(7):453–459. doi: 10.3109/08916934.2015.1070836
   PubMed Web of Science ®Google Scholar
• von Glehn F, Jarius S, de Oliveira AC P, et al. Aquaporin-4 antibodies are not related to HTLV-1 associated myelopathy. PLoS One. 2012;7(7):e39372. doi: 10.1371/journal.pone.0039372
   PubMed Web of Science ®Google Scholar
• Izumi Y, Kojima H, Koga Y, et al. Successful treatment of HTLV-1-related overlap syndrome using tacrolimus. Intern Med. 2011;50(17):1849–1853. doi: 10.2169/internalmedicine.50.5013
   PubMed Web of Science ®Google Scholar
• Nakamaru Y, Ishizu A, Ikeda H, et al. Immunological hyperresponsiveness in HTLV-I LTR-env-pX transgenic rats: a prototype animal model for collagen vascular and HTLV-I-related inflammatory diseases. Pathobiology. 2001;69(1):11–18. doi: 10.1159/000048752
   PubMed Web of Science ®Google Scholar
• Satou Y, Yasunaga J, Zhao T, et al. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLOS Pathog. 2011;7(2):e1001274. doi: 10.1371/journal.ppat.1001274
   PubMed Web of Science ®Google Scholar
• Diamantopoulos PT, Michael M, Benopoulou O, et al. Antiretroviral activity of 5-azacytidine during treatment of a HTLV-1 positive myelodysplastic syndrome with autoimmune manifestations. Virol J. 2012;9(1):1. doi: 10.1186/1743-422X-9-1
   PubMedGoogle Scholar
• Bathon JM, Martin RW, Fleischmann RM, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med. 2000;343(22):1586–1593. doi: 10.1056/NEJM200011303432201
   PubMed Web of Science ®Google Scholar
• Leonardi CL, Powers JL, Matheson RT, et al. Etanercept as monotherapy in patients with psoriasis. N Engl J Med. 2003;349(21):2014–2022. doi: 10.1056/NEJMoa030409
   PubMed Web of Science ®Google Scholar
• Horiguchi N, Kamoi K, Horie S, et al. A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behcet’s syndrome. Sci Rep. 2020;10(1):22227. doi: 10.1038/s41598-020-78718-z
   PubMed Web of Science ®Google Scholar
• Toussirot E, Aubin F. Paradoxical reactions under TNF-alpha blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview. RMD Open. 2016;2(2):e000239. doi: 10.1136/rmdopen-2015-000239
   PubMed Web of Science ®Google Scholar
• Wendling D, Prati C. Paradoxical effects of anti-TNF-alpha agents in inflammatory diseases. Expert Rev Clin Immunol. 2014;10(1):159–169. doi: 10.1586/1744666X.2014.866038
   PubMed Web of Science ®Google Scholar
• Palucka AK, Blanck JP, Bennett L, et al. Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc Natl Acad Sci U S A. 2005;102(9):3372–3377. doi: 10.1073/pnas.0408506102
   PubMed Web of Science ®Google Scholar
• Daien CI, Monnier A, Claudepierre P, et al. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology (Oxford). 2009;48(8):883–886. doi: 10.1093/rheumatology/kep046
   PubMed Web of Science ®Google Scholar
• Terada Y, Kamoi K, Ohno-Matsui K, et al. Treatment of rheumatoid arthritis with biologics may exacerbate HTLV-1-associated conditions: a case report. Medicine (Baltimore). 2017;96(6):e6021. doi: 10.1097/MD.0000000000006021
   PubMed Web of Science ®Google Scholar
• Pinon JD, Klasse PJ, Jassal SR, et al. Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans. J Virol. 2003;77(18):9922–9930. doi: 10.1128/JVI.77.18.9922-9930.2003
   PubMed Web of Science ®Google Scholar
• Jones KS, Petrow-Sadowski C, Bertolette DC, et al. Heparan sulfate proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4+ T cells. J Virol. 2005;79(20):12692–12702. doi: 10.1128/JVI.79.20.12692-12702.2005
   PubMed Web of Science ®Google Scholar
• Lambert S, Bouttier M, Vassy R, et al. HTLV-1 uses HSPG and neuropilin-1 for entry by molecular mimicry of VEGF165. Blood. 2009;113(21):5176–5185. doi: 10.1182/blood-2008-04-150342
   PubMed Web of Science ®Google Scholar
• Kamoi K, Okayama A, Izumo S, et al. Adult T-Cell leukemia/Lymphoma-related ocular manifestations: analysis of the first large-scale nationwide survey. Front Microbiol. 2018;9:3240. doi: 10.3389/fmicb.2018.03240
   PubMed Web of Science ®Google Scholar
• Kamoi K, Nagata Y, Mochizuki M, et al. Formation of segmental rounded nodules during infiltration of adult T-Cell leukemia cells into the ocular mucous membrane. Cornea. 2016;35(1):137–139. doi: 10.1097/ICO.0000000000000689
   PubMed Web of Science ®Google Scholar
• Mochizuki M, Sugita S, Kamoi K, et al. A new era of uveitis: impact of polymerase chain reaction in intraocular inflammatory diseases. Jpn J Ophthalmol. 2017;61(1):1–20. doi: 10.1007/s10384-016-0474-9
   PubMed Web of Science ®Google Scholar
• Kamoi K, Ohno-Matsui K. Intraocular infiltration. Am J Trop Med Hyg. 2020;102(1):7–8. doi: 10.4269/ajtmh.19-0539
   PubMed Web of Science ®Google Scholar
• Liu MM, Furusato E, Cao X, et al. Ocular Manifestations and Pathology of Adult T-cell Leukemia/Lymphoma Associated with Human T-lymphotropic virus Type 1. Ra Tum. 2010;2(4):e63. https://journals.sagepub.com/doi/full/10.4081/rt.2010.e63?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org
   PubMedGoogle Scholar
• Akaike S, Kamoi K, Tezuka M, et al. Ocular manifestation in myeloid/NK cell precursor acute leukemia: a case report. Diagnosed by flow cytometry and PCR from aqueous humor. Medicine (Baltimore). 2016;95(38):e4967. doi: 10.1097/MD.0000000000004967
   PubMed Web of Science ®Google Scholar
• Tsukasaki K, Tobinai K, Hotta T, et al. Lymphoma study group of JCOG. Jpn J Clin Oncol. 2012;42(2):85–95. doi: 10.1093/jjco/hyr168
   PubMed Web of Science ®Google Scholar
• Gill PS, Harrington W Jr., Kaplan MH, et al. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med. 1995;332(26):1744–1748. doi: 10.1056/NEJM199506293322603
   PubMed Web of Science ®Google Scholar
• Ishida T, Joh T, Uike N, et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. J Clin Oncol. 2012;30(8):837–842. doi: 10.1200/JCO.2011.37.3472
   PubMed Web of Science ®Google Scholar
• Zell M, Assal A, Derman O, et al. Adult T-cell leukemia/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapy. Oncotarget. 2016;7(32):51981–51990. doi: 10.18632/oncotarget.10223
   PubMedGoogle Scholar
• Suehiro Y, Hasegawa A, Iino T, et al. Clinical outcomes of a novel therapeutic vaccine with Tax peptide-pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study. Br J Haematol. 2015;169(3):356–367. doi: 10.1111/bjh.13302
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Kiyosawa M, Kawasaki T, et al. Successfully treated optic nerve infiltration with adult T-cell lymphoma. J Neuroophthalmol. 1994;14(2):81–83. doi: 10.1097/00041327-199406000-00005
   PubMed Web of Science ®Google Scholar
• Sugita S, Kamoi K, Ogawa M, et al. Detection of Candida and aspergillus species DNA using broad-range real-time PCR for fungal endophthalmitis. Graefes Arch Clin Exp Ophthalmol. 2012;250(3):391–398. doi: 10.1007/s00417-011-1819-1
   PubMed Web of Science ®Google Scholar
• Gilbert C, Boivin G. Human cytomegalovirus resistance to antiviral drugs. Antimicrob Agents Chemother. 2005;49(3):873–883. doi: 10.1128/AAC.49.3.873-883.2005
   PubMed Web of Science ®Google Scholar
• Campos AB, Ribeiro J, Boutolleau D, et al. Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art. Rev Med Virol. 2016;26(3):161–182. doi: 10.1002/rmv.1873
   PubMed Web of Science ®Google Scholar
• Cantorna MT, Balish E. Acquired immunity to systemic candidiasis in immunodeficient mice. J Infect Dis. 1991;164(5):936–943. doi: 10.1093/infdis/164.5.936
   PubMed Web of Science ®Google Scholar
• Goto K, Sugita M, Okada K, et al. Recurrent episcleritis associated with adult T cell leukaemia. Br J Ophthalmol. 1993;77(11):743–744. doi: 10.1136/bjo.77.11.743
   PubMed Web of Science ®Google Scholar
• Oono S, Kurimoto T, Oku H, et al. Adult T-cell leukemia presenting with episcleritis and secondary glaucoma. Jpn J Ophthalmol. 2009;53(1):70–71. doi: 10.1007/s10384-008-0599-6
   PubMed Web of Science ®Google Scholar
• Larson TA, Hu M, Janik JE, et al. Interleukin-2 receptor targeted therapy of ocular disease of HTLV-1-associated adult T-cell leukemia. Ocul Immunol Inflamm. 2012;20(4):312–314. doi: 10.3109/09273948.2012.689071
   PubMed Web of Science ®Google Scholar
• Hirano M, Ohno N, Tanosaki R, et al. Adult T-cell leukemia cell-induced uveitis: rapid increase in adult T-cell leukemia cells disrupts the blood-ocular barrier. Int J Hematol. 2017;106(6):842–846. doi: 10.1007/s12185-017-2293-2
   PubMed Web of Science ®Google Scholar
• Tsukasaki K, Marcais A, Nasr R, et al. Diagnostic approaches and Established treatments for adult T cell leukemia lymphoma. Front Microbiol. 2020;11:1207. doi: 10.3389/fmicb.2020.01207
   PubMed Web of Science ®Google Scholar
• Ogonek J, Kralj Juric M, Ghimire S, et al. Immune reconstitution after allogeneic hematopoietic stem cell transplantation. Front Immunol. 2016;7:507. doi: 10.3389/fimmu.2016.00507
   PubMed Web of Science ®Google Scholar
• Kamoi K, Kato S, Uchimaru K, et al. Frosted branch angiitis after allogeneic haematopoietic stem cell transplantation in adult T-cell leukaemia-lymphoma. Lancet Haematol. 2020;7(10):e772. doi: 10.1016/S2352-3026(20)30226-X
   PubMed Web of Science ®Google Scholar
• Coffin JM. The discovery of HTLV-1, the first pathogenic human retrovirus. Proc Natl Acad Sci U S A. 2015;112(51):15525–15529. doi: 10.1073/pnas.1521629112
   PubMed Web of Science ®Google Scholar
• Beilke MA. Human T-cell lymphotropic virus type I-associated uveitis in an African American. Am J Ophthalmol. 1995;119(1):104–105. doi: 10.1016/S0002-9394(14)73827-9
   PubMed Web of Science ®Google Scholar
• White SL, Rawlinson W, Boan P, et al. Infectious disease transmission in Solid Organ transplantation: donor evaluation, recipient risk, and outcomes of transmission. Transplant Direct. 2019;5(1):e416. doi: 10.1097/TXD.0000000000000852
   PubMed Web of Science ®Google Scholar
• Casoli C, Pilotti E, Bertazzoni U. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression. AIDS Rev. 2007;9(3):140–149.
   PubMed Web of Science ®Google Scholar
• Mulherkar TH, Gomez DJ, Sandel G, et al. Co-infection and Cancer: Host–pathogen interaction between dendritic cells and HIV-1, HTLV-1, and other oncogenic Viruses. Viruses. 2022;14(9):2037. doi: 10.3390/v14092037
   PubMed Web of Science ®Google Scholar
• Montano-Castellon I, Marconi CSC, Saffe C, et al. Clinical and laboratory outcomes in HIV-1 and HTLV-1/2 Coinfection: a systematic review. Front Public Health. 2022;10:820727. doi: 10.3389/fpubh.2022.820727
   PubMed Web of Science ®Google Scholar
• Olek K, Uhlhaas S, Wardenbach P, et al. Influence of storing conditions on the amino acid concentration in human serum (author’s transl). J Clin Chem Clin Biochem. 1979;17(9):599–604. doi: 10.1515/cclm.1979.17.9.599
   PubMedGoogle Scholar